Updates

We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.

• 17 June 2022
  

  A Leap of Pride
• 13 June 2022

  Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis

  The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics.
• 10 June 2022

  Global Fund's Seventh Replenishment: How Can Implementing Countries Support?
• 31 May 2022

  47th Board Meeting Documents
• 20 May 2022

  External Quality Assessment: Highest Possible Results for OIG Audit and Investigation Units
• 20 May 2022

  Refocusing C19RM Investments to Maximize Impact

  The COVID-19 pandemic is evolving and so should C19RM investments. The Global Fund would like to support implementing countries to rethink how these funds need to be adapted to countries’ needs in a very dynamic pandemic context.
• 20 May 2022

  New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP

  The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India
• 10 May 2022
  

  Pandemic Preparedness and Response - Thematic Report
• 04 May 2022

  COVID-19 Clinical Therapeutics

  In this operational update, we would like to give you an update on COVID-19 testing and therapeutics that can be currently supported through the Global Fund’s COVID-19 Response Mechanism (C19RM), following WHO guidelines.
• 03 May 2022

  Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department

  The Global Fund is pleased to announce the appointment of Susie Rhee as the new General Counsel and Head of the Legal & Governance Department.